BBDA News 0.0010 06/20/2014 04:28:21 Bebida Beverage Co (BBD

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bebida Beverage Co (BBDA) 0.0010 $BBDA

BeBevCo Adds Cheech and Chong Chillaxation Drink® To Its Liquid Relaxation Beverage Lineup
PR Newswire - Mon Jun 09, 9:10AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products, announced today that the company and its partially owned subsidiary, Relaxations Solutions Inc., have "doubled down" on the very well developed Cheech and Chong brand with the addition of Cheech and Chong Chillaxation drink®.

BeBevCo Adds New PepsiCo Distributor For Crucial Northwest Coast Expansion Push
PR Newswire - Thu May 22, 8:44AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products, announced today that the company has partnered with the Walton Beverage Co.

BeBevCo's KOMA Unwind Partners With Racing Veteran Jeremy Mayfield
PR Newswire - Tue May 20, 9:00AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products, announced today that the company has partnered with veteran racer Jeremy Mayfield.

BeBevCo's KOMA Unwind Renews With Shameless Racing
PR Newswire - Thu May 15, 8:30AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products, announced today that the company has renewed its partnership with Brandon Kennedy and Shameless Racing.

BeBevCo Adds Two Key Players To Growing Company's Platform
PR Newswire - Tue Apr 29, 8:50AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products, announced today that the company added two key individuals to its growing company lineup.

BeBevCo Partners With Emmy Award Nominated Actress Carolyn Hennesy
PR Newswire - Wed Apr 23, 8:30AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products, announced today that the company has partnered with Emmy Award-nominated actress Carolyn Hennesy and her radio program, Animal Magnetism.

BeBevCo To Continue Support Of Military On Memorial Day Weekend
PR Newswire - Thu Apr 17, 9:00AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of liquid relaxation and energy products, is pleased to announce that as part of their 2014 marketing initiative, the Southern Modified Race Tour's KOMA Unwind Modified Madness Series (@KOMAUnwindMMS) heads to Jacksonville. NC, home to Camp Lejeune, for the running of the "Semper Fi 125" on Sunday, May 25th.

BeBevCo Continues To Draw Media Attention With FOX 46 Feature
PR Newswire - Fri Mar 28, 8:55AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products, announced today that the company has been the subject of a series of headliners that have kept the Statesville, North Carolina-based team in the spotlight.

BeBevCo Serves up Nice Dreams for Shareholders and Sweet Tooth's with Cheech and Chong-branded Relaxation Ice Cream
PR Newswire - Mon Mar 24, 8:55AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of relaxation and energy products, is pleased to announce that its subsidiary, Relaxation Solutions, Inc. (RSI), has secured a multi-year licensing agreement to brand its new-to-market line of Relaxation Ice Cream utilizing powerhouse icons, Cheech and Chong, and their classic movie," Cheech & Chong's Nice Dreams" for a branding opportunity never before seen in this market space.

BeBevCo Recaps Q1 for Shareholders in Preparation for Major Licensing Announcement For Subsidiary
PR Newswire - Wed Mar 19, 8:55AM CDT
Bebida Beverage Company (OTC: BBDA), (BeBevCo), a developer, manufacturer and marketer of liquid relaxation and energy products, is pleased to offer shareholders a summary of 2014 to date in the wake of a major licensing agreement, which the company plans to announce in the coming days.

BeBevCo Ramps Up For Upcoming Events
PR Newswire - Thu Mar 13, 9:14AM CDT
Bebida Beverage Company (OTC markets: BBDA) (BeBevCo), a developer, manufacturer and marketer of Relaxation drinks and energy products, announced today the company is actively preparing for several upcoming events to promote the company's flagship products, KOMA Unwind relaxation drink and its two-ounce shots.

Dangdang Announces Fourth Quarter and Fiscal Year 2013 Results
PR Newswire - Thu Feb 27, 5:47AM CST
E-Commerce China Dangdang Inc. ("Dangdang" or the "Company" (NYSE: DANG), a leading business-to-consumer e-commerce company in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2013.

BeBevCo Daytona Bound With Participation In NASCAR Events
PR Newswire - Thu Feb 20, 12:00PM CST
Bebida Beverage Company (OTC markets: BBDA) (BeBevCo), a developer, manufacturer and marketer of Relaxation drinks and energy products, announced today that the company will partner with two NASCAR teams for the approaching 2014 NASCAR season openers this weekend.

Concise Analysis of the International Commercial Aircraft Leasing Market
PR Newswire - Wed Feb 19, 8:43AM CST
Research and Markets

BeBevCo Adds Another Distributor To Feature Flagship Product
PR Newswire - Wed Feb 19, 8:40AM CST
Bebida Beverage Company (OTC markets: BBDA) (BeBevCo), a developer, manufacturer and marketer of Relaxation drinks and energy products, announced today that the company has entered into a distribution agreement with Hub Distributing.

KOMA Unwind Relaxation Drink Featured In Oprah Winfrey's "O" Magazine
PR Newswire - Tue Feb 18, 8:00AM CST
Bebida Beverage Company (OTC markets: BBDA) (BeBevCo), a developer, manufacturer and marketer of Relaxation drinks and energy products, announced today that the company's flagship brand KOMA Unwind relaxation drink will be featured in March's edition of "O" magazine.

Pharmacyclics Announces Date of Conference call to discuss Financial Results for Fourth Quarter and Year End 2013
PR Newswire - Fri Feb 14, 2:45PM CST
Pharmacyclics, Inc. (the "Company" (Nasdaq: PCYC) today announced that it will hold a conference call and audio webcast to discuss financial results for its fourth quarter and full year ended December 31, 2013 after the NASDAQ Market closes on Thursday, February 20, 2014 at 4:30 p.m. ET.

Former Texas Supreme Court Justice Dale Wainwright Discusses the Importance of Educating Texas Voters About Judicial Candidates
PR Newswire - Fri Feb 14, 11:33AM CST
The Texas Civil Justice League (TCJL) has released a new video featuring former Texas Supreme Court Justice Dale Wainwright discussing the importance of voting for candidates who are most qualified for the judiciary.

Analysis of the Global Mobile Endpoint Protection Market
PR Newswire - Wed Feb 12, 9:00AM CST
Dublin - Research and Markets (http://www.researchandmarkets.com/research/fnwwx7/analysis_of_the) has announced the addition of the"Analysis of the Global Mobile Endpoint Protection Market" report to their offering.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 514

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 391

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 182

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 225

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

HALiXPEDITE Revolutionizes Biologics Therapy Development Process

Updated Category News Views 147

HALiXPEDITE: Transforming the Future of Biologics Development HALIX, a prominent global healthcare Contract Development and Manufacturing Organization (CDMO), recently unveiled its innovative platform, HALiXPEDITE, at a notable conference. This platform is specifically designed to expedite the development of biologics therapies, focusing on a streamlined approach to...

Continue Reading
Day One Biopharmaceuticals to Share Q3 2025 Insights

Updated Category News Views 170

Day One Biopharmaceuticals to Present Q3 2025 Financial Results In a busy season for the biopharmaceutical industry, Day One Biopharmaceuticals (Nasdaq: DAWN) has announced it will host a live conference call and webcast aimed at reporting its financial results and outlining corporate progress for the third quarter of 2025. Conference Call Details The event is scheduled...

Continue Reading
Leica Biosystems Promotes DICOM Standards for Digital Pathology

Updated Category News Views 114

Leica Biosystems Promotes DICOM Standards for Digital Pathology Leica Biosystems, a prominent figure in anatomic pathology, has recently made waves in the medical field with a bold new initiative. By announcing the non-enforcement of their Digital Pathology DICOM (Digital Imaging and Communications in Medicine) patent portfolio, they aim to boost the implementation of...

Continue Reading
LYNPARZA: A Breakthrough in Early Breast Cancer Treatments

Updated Category News Views 288

Significant Survival Benefits with LYNPARZA in Breast Cancer Recent findings from the OlympiA Phase III trial bring exciting news for patients battling early breast cancer. AstraZeneca and Merck & Co., Inc.'s LYNPARZA (olaparib) has showcased profound improvements in survival rates among patients with germline BRCA-mutated HER2-negative high-risk early breast cancer. This...

Continue Reading
EuroDry Limited's Stock Experiences Volatility Amid Challenges

Updated Category News Views 229

EuroDry Limited Faces Stock Turmoil EuroDry Ltd. (NASDAQ: EDRY), a leading provider in drybulk shipping, has recently encountered a tumultuous phase, with its stock reaching a noteworthy low at $14.1. This decline marks a significant reflection on the year's challenges the company has faced, indicated by a -14.71% change over the past year. Market Conditions and...

Continue Reading